<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="ab005">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="l0005">
   <list-item id="o0005">
    <label>•</label>
    <p id="p0005">SARS and MERS-CoV infrequently cause neurological complications, symptoms delayed by 14–25 days.</p>
   </list-item>
   <list-item id="o0010">
    <label>•</label>
    <p id="p0010">SARS-CoV-2 neurological consequences are common with early presentation (1–2) days.</p>
   </list-item>
   <list-item id="o0015">
    <label>•</label>
    <p id="p0015">Anticoagulants linked to thrombotic complexities.</p>
   </list-item>
   <list-item id="o00115">
    <label>•</label>
    <p id="p003215">Methylprednisolone is associated with myopathy.</p>
   </list-item>
   <list-item id="o0020">
    <label>•</label>
    <p id="p0020">The COVID 19 ageusia/anosmia, myalgia and central nervous pathologies warrants future exploration.</p>
   </list-item>
  </list>
 </p>
</abstract>
